Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer [Phase 1, Phase 2]
A dose-escalation study evaluating the combination of Trastuzumab Emtansine (T-DM1) with Neratinib in women with metastatic HER2-positive br…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial of talimogene laherparepvec for recurrent breast cancer that cannot be removed surgically has been terminated; result…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Contrast Ultrasound Detection of Sentinel Lymph Nodes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating contrast-enhanced ultrasound for detection of sentinel lymph nodes in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer [Phase 3]
Phase 3 trial comparing EG12014 to Herceptin in HER2-positive early breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line [Phase 3]
A Phase 3 trial assessing ribociclib with endocrine therapy or chemotherapy, with or without bevacizumab, as first-line treatment for metast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial of an anti-PD-1 antibody with radiation therapy in HER2-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases [Phase 1, Phase 2]
A clinical trial evaluating pyrotinib combined with brain radiotherapy for patients with breast cancer and brain metastases (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients. [Phase 3]
Phase 3 trial update evaluating olaparib monotherapy for metastatic breast cancer focused on HER2-negative disease with germline BRCA1/2 mut…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women [Phase 3]
Phase 3 trial update on adjuvant ovarian suppression plus aromatase inhibitor or tamoxifen in young women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a multi-epitope folate receptor alpha peptide vaccine with GM-CSF and cyclophosphamide for treating triple…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer [Phase 2]
Phase II study evaluating pembrolizumab with chemotherapy as neoadjuvant therapy for triple-negative breast cancer is ongoing with status no…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer [Phase 3]
Phase 3 trial evaluating SPY-X for sentinel node localization in melanoma and breast cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC [Phase 2]
Phase 2 trial evaluating pembrolizumab with gemcitabine in HER2-negative advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer [Phase 2]
Phase 2 study evaluating bevacizumab in combination with neoadjuvant regimens for HER2-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy [Phase 4]
Phase 4 clinical trial evaluating targeted axillary lymph node dissection in node-positive breast cancer patients after neoadjuvant therapy.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Feasibility Study of Intraoperative Imaging in Breast Cancer [Phase 1, Phase 2]
Feasibility study results for intraoperative imaging in breast cancer completed; multi-phase (Phase 1 and Phase 2) trial results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial update evaluating CDK4/6 inhibitors as second-line treatment for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial update assessing the safety of ovarian function suppression (OFS) combined with AI endocrine therapy in Chinese pre…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating eribulin followed by the AC chemotherapy regimen as preoperative therapy for HER2-negative inflammatory breast canc…
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating laboratory-treated T cells after second-line chemotherapy in patients with HER2/Neu-negative metastatic …
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Clinician Communication About Sexual Health [NA]
Completed clinical trial assessing clinician communication about sexual health in breast cancer care; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery [Phase 2]
A Phase 2 trial evaluating hypofractionated radiation therapy before surgery in breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 trial update evaluating Pyrotinib in combination with Capecitabine for trastuzumab-resistant HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Evaluation of Breast CT [NA]
Clinical trial update for Evaluation of Breast CT completed; results posted in 2022.